2 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Filariasis: new trials by email Literature Review of Filariasis trials Research Report on Filariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis | Phase 2 / Phase 3 | Unknown | Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 99 | 2024-06-21 | 2024-09-20 |
| Emodepside Phase II Trial for Treatment of Onchocerciasis emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis | Phase 2 | Unknown | Drugs for Neglected Diseases | 578 | 2021-08-30 | 2024-03-05 |
Onchocerciasis (2) · Helminthiasis (1) · Loiasis (1) · Neglected Diseases (1) · Nematode Infections (1) · Onchocerciasis, Ocular (1) · Parasitic Diseases (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Parasitic (1)
Infections (2) · Secernentea Infections (2) · Skin and Connective Tissue Diseases (2) · Spirurida Infections (2) · Disease Attributes (1) · Eye Diseases (1) · Eye Infections (1) · Eye Infections, Parasitic (1) · Helminthiasis (1) · Nematode Infections (1) · Parasitic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Infectious (1)
Bay 44-4400 (1) · Ivermectin (1) · Levamisole (1) · emodepside (1)
Drugs for Neglected Diseases (1) · Programme National de Lutte contre l'Onchocercose, Republic of the Congo (1)
Democratic Republic of the Congo (1) · Ghana (1) · Republic of the Congo (1)